High-Dose Chemotherapy with Hematopoietic Stem Cell Transplant in Patients with High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

MLA

Speerpunt Cancer, et al. High-Dose Chemotherapy with Hematopoietic Stem Cell Transplant in Patients with High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432114355&authtype=sso&custid=ns315887.

APA

Speerpunt Cancer, Cancer, Steenbruggen, T. G., Steggink, L. C., Seynaeve, C. M., Van Der Hoeven, J. J. M., Hooning, M. J., Jager, A., Konings, I. R., Kroep, J. R., Smit, W. M., Tjan-Heijnen, V. C. G., Van Der Wall, E., Bins, A. D., Linn, S. C., Schaapveld, M., Jacobse, J. N., Van Leeuwen, F. E., Schröder, C. P., … Gietema, J. A. (2020). High-Dose Chemotherapy with Hematopoietic Stem Cell Transplant in Patients with High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.

Chicago

Speerpunt Cancer, Cancer, Tessa G. Steenbruggen, Lars C. Steggink, Caroline M. Seynaeve, Jacobus J.M. Van Der Hoeven, Maartje J. Hooning, et al. 2020. “High-Dose Chemotherapy with Hematopoietic Stem Cell Transplant in Patients with High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432114355&authtype=sso&custid=ns315887.